Copyright Reports & Markets. All rights reserved.

Global Cardiovascular Implant Materials Market Research Report 2022

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
  • 1.2.1 Global Cardiovascular Implant Materials Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Coronary Drug Eluting Stent
  • 1.2.3 Artificial Heart Valve
  • 1.2.4 Balloon Dilatation Catheter
  • 1.2.5 Guide Wire
  • 1.2.6 Others
  • 1.3 Market by Application
  • 1.3.1 Global Cardiovascular Implant Materials Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Cardiovascular Implant Materials Market Perspective (2017-2028)
    • 2.2 Cardiovascular Implant Materials Growth Trends by Region
    • 2.2.1 Cardiovascular Implant Materials Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Cardiovascular Implant Materials Historic Market Size by Region (2017-2022)
  • 2.2.3 Cardiovascular Implant Materials Forecasted Market Size by Region (2023-2028)
  • 2.3 Cardiovascular Implant Materials Market Dynamics
  • 2.3.1 Cardiovascular Implant Materials Industry Trends
  • 2.3.2 Cardiovascular Implant Materials Market Drivers
  • 2.3.3 Cardiovascular Implant Materials Market Challenges
  • 2.3.4 Cardiovascular Implant Materials Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top Cardiovascular Implant Materials Players by Revenue
    • 3.1.1 Global Top Cardiovascular Implant Materials Players by Revenue (2017-2022)
  • 3.1.2 Global Cardiovascular Implant Materials Revenue Market Share by Players (2017-2022)
  • 3.2 Global Cardiovascular Implant Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Cardiovascular Implant Materials Revenue
  • 3.4 Global Cardiovascular Implant Materials Market Concentration Ratio
  • 3.4.1 Global Cardiovascular Implant Materials Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular Implant Materials Revenue in 2021
  • 3.5 Cardiovascular Implant Materials Key Players Head office and Area Served
  • 3.6 Key Players Cardiovascular Implant Materials Product Solution and Service
  • 3.7 Date of Enter into Cardiovascular Implant Materials Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Cardiovascular Implant Materials Breakdown Data by Type

    • 4.1 Global Cardiovascular Implant Materials Historic Market Size by Type (2017-2022)
    • 4.2 Global Cardiovascular Implant Materials Forecasted Market Size by Type (2023-2028)

    5 Cardiovascular Implant Materials Breakdown Data by Application

    • 5.1 Global Cardiovascular Implant Materials Historic Market Size by Application (2017-2022)
    • 5.2 Global Cardiovascular Implant Materials Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Cardiovascular Implant Materials Market Size (2017-2028)
    • 6.2 North America Cardiovascular Implant Materials Market Size by Country (2017-2022)
    • 6.3 North America Cardiovascular Implant Materials Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe Cardiovascular Implant Materials Market Size (2017-2028)
    • 7.2 Europe Cardiovascular Implant Materials Market Size by Country (2017-2022)
    • 7.3 Europe Cardiovascular Implant Materials Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Cardiovascular Implant Materials Market Size (2017-2028)
    • 8.2 Asia-Pacific Cardiovascular Implant Materials Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific Cardiovascular Implant Materials Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America Cardiovascular Implant Materials Market Size (2017-2028)
    • 9.2 Latin America Cardiovascular Implant Materials Market Size by Country (2017-2022)
    • 9.3 Latin America Cardiovascular Implant Materials Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Cardiovascular Implant Materials Market Size (2017-2028)
    • 10.2 Middle East & Africa Cardiovascular Implant Materials Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa Cardiovascular Implant Materials Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Boston Scientific
    • 11.1.1 Boston Scientific Company Detail
  • 11.1.2 Boston Scientific Business Overview
  • 11.1.3 Boston Scientific Cardiovascular Implant Materials Introduction
  • 11.1.4 Boston Scientific Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.1.5 Boston Scientific Recent Development
  • 11.2 Medtronic
  • 11.2.1 Medtronic Company Detail
  • 11.2.2 Medtronic Business Overview
  • 11.2.3 Medtronic Cardiovascular Implant Materials Introduction
  • 11.2.4 Medtronic Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.2.5 Medtronic Recent Development
  • 11.3 Biosensors
  • 11.3.1 Biosensors Company Detail
  • 11.3.2 Biosensors Business Overview
  • 11.3.3 Biosensors Cardiovascular Implant Materials Introduction
  • 11.3.4 Biosensors Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.3.5 Biosensors Recent Development
  • 11.4 Abbott
  • 11.4.1 Abbott Company Detail
  • 11.4.2 Abbott Business Overview
  • 11.4.3 Abbott Cardiovascular Implant Materials Introduction
  • 11.4.4 Abbott Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.4.5 Abbott Recent Development
  • 11.5 Biotronik
  • 11.5.1 Biotronik Company Detail
  • 11.5.2 Biotronik Business Overview
  • 11.5.3 Biotronik Cardiovascular Implant Materials Introduction
  • 11.5.4 Biotronik Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.5.5 Biotronik Recent Development
  • 11.6 Terumo
  • 11.6.1 Terumo Company Detail
  • 11.6.2 Terumo Business Overview
  • 11.6.3 Terumo Cardiovascular Implant Materials Introduction
  • 11.6.4 Terumo Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.6.5 Terumo Recent Development
  • 11.7 B.Braun
  • 11.7.1 B.Braun Company Detail
  • 11.7.2 B.Braun Business Overview
  • 11.7.3 B.Braun Cardiovascular Implant Materials Introduction
  • 11.7.4 B.Braun Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.7.5 B.Braun Recent Development
  • 11.8 Edwards
  • 11.8.1 Edwards Company Detail
  • 11.8.2 Edwards Business Overview
  • 11.8.3 Edwards Cardiovascular Implant Materials Introduction
  • 11.8.4 Edwards Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.8.5 Edwards Recent Development
  • 11.9 Meril Life Sciences Pvt
  • 11.9.1 Meril Life Sciences Pvt Company Detail
  • 11.9.2 Meril Life Sciences Pvt Business Overview
  • 11.9.3 Meril Life Sciences Pvt Cardiovascular Implant Materials Introduction
  • 11.9.4 Meril Life Sciences Pvt Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.9.5 Meril Life Sciences Pvt Recent Development
  • 11.10 Vascular Concepts
  • 11.10.1 Vascular Concepts Company Detail
  • 11.10.2 Vascular Concepts Business Overview
  • 11.10.3 Vascular Concepts Cardiovascular Implant Materials Introduction
  • 11.10.4 Vascular Concepts Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.10.5 Vascular Concepts Recent Development
  • 11.11 Translumina GmbH (Germany)
  • 11.11.1 Translumina GmbH (Germany) Company Detail
  • 11.11.2 Translumina GmbH (Germany) Business Overview
  • 11.11.3 Translumina GmbH (Germany) Cardiovascular Implant Materials Introduction
  • 11.11.4 Translumina GmbH (Germany) Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.11.5 Translumina GmbH (Germany) Recent Development
  • 11.12 LanFei Mede
  • 11.12.1 LanFei Mede Company Detail
  • 11.12.2 LanFei Mede Business Overview
  • 11.12.3 LanFei Mede Cardiovascular Implant Materials Introduction
  • 11.12.4 LanFei Mede Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.12.5 LanFei Mede Recent Development
  • 11.13 Balance Medical
  • 11.13.1 Balance Medical Company Detail
  • 11.13.2 Balance Medical Business Overview
  • 11.13.3 Balance Medical Cardiovascular Implant Materials Introduction
  • 11.13.4 Balance Medical Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.13.5 Balance Medical Recent Development
  • 11.14 Blue Sail
  • 11.14.1 Blue Sail Company Detail
  • 11.14.2 Blue Sail Business Overview
  • 11.14.3 Blue Sail Cardiovascular Implant Materials Introduction
  • 11.14.4 Blue Sail Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.14.5 Blue Sail Recent Development
  • 11.15 Lepumedical
  • 11.15.1 Lepumedical Company Detail
  • 11.15.2 Lepumedical Business Overview
  • 11.15.3 Lepumedical Cardiovascular Implant Materials Introduction
  • 11.15.4 Lepumedical Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.15.5 Lepumedical Recent Development
  • 11.16 Micro Port
  • 11.16.1 Micro Port Company Detail
  • 11.16.2 Micro Port Business Overview
  • 11.16.3 Micro Port Cardiovascular Implant Materials Introduction
  • 11.16.4 Micro Port Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.16.5 Micro Port Recent Development
  • 11.17 SINOMED
  • 11.17.1 SINOMED Company Detail
  • 11.17.2 SINOMED Business Overview
  • 11.17.3 SINOMED Cardiovascular Implant Materials Introduction
  • 11.17.4 SINOMED Revenue in Cardiovascular Implant Materials Business (2017-2022)
  • 11.17.5 SINOMED Recent Development
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Disclaimer
    • Cardiovascular disease treatment technologies include drug therapy, surgical treatment, and interventional therapy. Among them, cardiovascular interventional therapy is widely used in clinical practice due to its advantages of small trauma, high safety and good therapeutic effect. Cardiovascular interventional therapy is a technique that enters the heart or blood vessels through vascular puncture to perform diagnosis or treatment.
      Industry Insights

      The global Cardiovascular Implant Materials market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

      Fully considering the economic change by this health crisis, Coronary Drug Eluting Stent accounting for % of the Cardiovascular Implant Materials global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.

      China Cardiovascular Implant Materials market size is valued at US$ million in 2021, while the North America and Europe Cardiovascular Implant Materials are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cardiovascular Implant Materials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiovascular Implant Materials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiovascular Implant Materials market in terms of revenue.

      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiovascular Implant Materials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiovascular Implant Materials market.

      Impact of Covid-19 Outbreak

      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

      Segmental Analysis

      The report has been segmented into product and application segments. The researchers have documented all the products present today in the Cardiovascular Implant Materials market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

      Cardiovascular Implant Materials Breakdown Data by Type

      Coronary Drug Eluting Stent

      Artificial Heart Valve

      Balloon Dilatation Catheter

      Guide Wire

      Others

      Cardiovascular Implant Materials Breakdown Data by Application

      Hospital

      Clinic

      Regional Analysis

      North America

      United States

      Canada

      Europe

      Germany

      France

      UK

      Italy

      Russia

      Nordic Countries

      Rest of Europe

      Asia-Pacific

      China

      Japan

      South Korea

      Southeast Asia

      India

      Australia

      Rest of Asia

      Latin America

      Mexico

      Brazil

      Rest of Latin America

      Middle East & Africa

      Turkey

      Saudi Arabia

      UAE

      Rest of MEA

      Competitive Landscape

      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

      Boston Scientific

      Medtronic

      Biosensors

      Abbott

      Biotronik

      Terumo

      B.Braun

      Edwards

      Meril Life Sciences Pvt

      Vascular Concepts

      Translumina GmbH (Germany)

      LanFei Mede

      Balance Medical

      Blue Sail

      Lepumedical

      Micro Port

      SINOMED

      Frequently Asked Questions

      What factors will challenge the Cardiovascular Implant Materials market growth?

      Which end-use segment will expand at the fastest CAGR in the Cardiovascular Implant Materials market?

      Which are the emerging players in the Cardiovascular Implant Materials market?

      How concentrated is the Cardiovascular Implant Materials market?

      Which factors are positively contributing to the Cardiovascular Implant Materials market growth?

      Which are the novel product innovations in the Cardiovascular Implant Materials market?

      Which product segment will emerge as the most lucrative in the Cardiovascular Implant Materials market?

      Which factors are increasing the competition in the Cardiovascular Implant Materials market?

      Which are the strategic measures taken by the Cardiovascular Implant Materials industry players?

      Which region will witness inactive growth during the forecast period?

      What key trends are likely to emerge in the Cardiovascular Implant Materials market in the coming years?

      Buy now